2020
DOI: 10.3390/jcm9093039
|View full text |Cite
|
Sign up to set email alerts
|

Risk Assessment Using Risk Scores in Patients with Acute Coronary Syndrome

Abstract: Risk scores are widely used in patients with acute coronary syndrome (ACS) prior to treatment decision-making at different points in time. At initial hospital presentation, risk scores are used to assess the risk for developing major adverse cardiac events (MACE) and can guide clinicians in either discharging the patients at low risk or swiftly admitting and treating the patients at high risk for MACE. During hospital admission, risk assessment is performed to estimate mortality, residual ischemic and bleeding… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
14
0
1

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 24 publications
(15 citation statements)
references
References 74 publications
0
14
0
1
Order By: Relevance
“…Acute coronary syndrome (ACS) constitutes the leading cause of morbidity and mortality worldwide [1,2]. Prospective risk stratification in patients with ACS, including unstable angina (UA), non-ST-segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial infarction (STEMI), facilitates decisions on the timing of angiography and thus enables a personalized therapeutic strategy [3,4]. Current American and European clinical guidelines suggest the use of a Global Registry of Acute Coronary Events (GRACE) risk score as a predictor of major adverse events in these patients [5][6][7].…”
Section: Introductionmentioning
confidence: 99%
“…Acute coronary syndrome (ACS) constitutes the leading cause of morbidity and mortality worldwide [1,2]. Prospective risk stratification in patients with ACS, including unstable angina (UA), non-ST-segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial infarction (STEMI), facilitates decisions on the timing of angiography and thus enables a personalized therapeutic strategy [3,4]. Current American and European clinical guidelines suggest the use of a Global Registry of Acute Coronary Events (GRACE) risk score as a predictor of major adverse events in these patients [5][6][7].…”
Section: Introductionmentioning
confidence: 99%
“…Further improvement was the inclusion of additional clinical and anatomic variables resulting in the SYNTAX II score [14]. Although these scores were developed to estimate patient prognosis and to provide optimal patient-oriented treatment, they are still largely underused [20]. Some of the main concerns are their development and validation in different clinical settings, across the entire spectrum of both stable and unstable patients, managed with different treatment strategies [21][22][23][24].…”
Section: Resultsmentioning
confidence: 99%
“…Furthermore, their prognostic strength was evaluated in different time-frames, from in-hospital outcomes to short-term and long-term follow-up [6,19]. Finally, the complexity of risk scores aggravates everyday clinical usage indicating the importance of simple clinical scores [20].…”
Section: Resultsmentioning
confidence: 99%
“…Original decision aid rule authors proposed managing the patient at the emergency department following the calculated risk. For example, safe discharge from the emergency department for low-risk groups, admission to the ward and invasive approach for high-risk groups, and additional examination such as serial troponin testing or stress/ imaging tests for moderaterisk groups [3]. Table 1 shows the summary of the selected decision aids.…”
Section: Decision Aid Rulesmentioning
confidence: 99%